Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease
about
Second consensus statement on the diagnosis of multiple system atrophyAbnormal Cerebrovascular Reactivity in Patients with Parkinson's Disease.Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease.Syndromes of orthostatic intolerance: a hidden danger.Current concepts in orthostatic hypotension management.Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.Orthostatic hypotension in drug-naïve patients with Parkinson's disease.Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.Management of neurogenic orthostatic hypotension: an update.Autonomic function in a prevalent Tanzanian population with Parkinson's disease and its relationship to disease duration and 5-year mortality.Prevalence, associations, and risk factors for orthostatic hypotension in medical, surgical, and trauma inpatients: an observational cohort study.Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.Evaluation and management of the non-motor features of Parkinson's disease.Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPSMechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis.Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.Neurotransmission in Parkinson's disease: beyond dopamine.Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.The management of orthostatic hypotension in Parkinson's disease.Orthostatic hypotension and cognitive impairment: a dangerous association?Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.Cardiovagal Baroreflex Sensitivity in Parkinson's Disease and Multiple-System Atrophy.Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).The relation of falls to fatigue, depression and daytime sleepiness in Parkinson's disease.Hard to swallow: dysphagia in Parkinson's disease.An update on the recognition and treatment of autonomic symptoms in Parkinson's disease.Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)Effects of mechanical stimulation of the feet on gait and cardiovascular autonomic control in Parkinson's disease
P2860
Q24650965-E74D870C-BBFA-4062-A77D-AD1CE4744EB9Q30407058-FBA0941E-F85D-495C-8CF6-8A9D7DA76D8AQ33159154-038092C4-3415-47EA-A739-0ABA07C0BB09Q33162112-CB52EB47-7D07-4C99-923E-68A09E7185FBQ33163010-45416BF3-B77B-46AB-9D45-1B7DEA97B04BQ33164125-88446135-5663-4CAF-BE83-9A3E7295BCC6Q33636379-4DC69208-3C97-4143-A4E3-7EB2212F3209Q33727242-57AED5D9-56B5-4DA1-AD8B-54E0342BA57EQ34140404-6C84AF73-5861-4849-9EA4-99E0BBBE0A5DQ34590699-8BE899FD-C7B9-4C85-A9FD-45FD673185FFQ35068238-F90BDAD6-DF14-4B02-9F64-087CF1B6A98EQ35839365-43478E26-2E3B-4132-8D71-E81F872B3544Q36226842-535DA4A5-5FE5-43D2-8EFB-18C2A1BE79CEQ36443721-C79D5A28-8855-4E27-B87E-2D56A7A4E43EQ36845017-A4CD4CD1-ABFE-4364-8BCD-4405419B1C92Q36969346-0267137F-B3DB-4015-B7BF-248B7B5E8945Q37016546-3A35BFF3-4B09-4200-BB4D-B34BC7269DF2Q37150169-880E8AB9-8E84-4E26-BFEB-930F4EE857C2Q37544921-CDD2499A-71FB-4C98-9FD4-B6F1ED75DEE4Q37593555-56485FA7-E0A9-4D86-B1DB-B9B524B844A2Q37668684-21D3B86B-D0EF-4D56-9B7A-5D235ED16D4CQ37711062-DDD747A6-CDC1-4890-BE4B-468D5705B7EFQ37872684-EB433E7F-6D91-46F9-99C5-1B11B6AF6B26Q38114882-8FC7FA67-1041-4801-B107-0E3F6DE2CAC0Q38192976-2DC44EB0-9F6A-4192-8AD2-6F6E82B47A43Q39393248-C73F08BA-5EA1-493E-8E6B-D74DAD0924E6Q40065210-DB980375-4724-42F2-982B-796547F287AEQ40495838-F8B94315-95A0-4105-9ECE-2857F5BA0902Q48686419-B84C15AB-BDA2-4DE1-8D2C-28C76C8241D5Q53222284-FFBBC1AD-F2E1-4C41-B6F0-DB63BC150E88Q53587610-65203B72-D77D-42DE-BE61-E7E36FABB152Q56564772-7F7C01AA-CEEC-49CB-A1E2-4DE10BF84AF3Q58859902-E0963C3A-887E-4881-8522-ACAA9CACD2E1
P2860
Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@ast
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@en
type
label
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@ast
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@en
prefLabel
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@ast
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@en
P2093
P356
P1476
Frequency of orthostatic hypot ...... ients with Parkinson's disease
@en
P2093
P304
P356
10.1136/JNNP.2003.029413
P407
P577
2004-10-01T00:00:00Z